Keyt BA - Search Results

1

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, et al. Aiello LP, et al. Among authors: keyt ba. N Engl J Med. 1994 Dec 1;331(22):1480-7. doi: 10.1056/NEJM199412013312203. N Engl J Med. 1994. PMID: 7526212 Free article.

2

Hypoxic regulation of vascular endothelial growth factor in retinal cells.

Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA. Aiello LP, et al. Among authors: keyt ba. Arch Ophthalmol. 1995 Dec;113(12):1538-44. doi: 10.1001/archopht.1995.01100120068012. Arch Ophthalmol. 1995. PMID: 7487623

3

Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis.

Keyt BA, Nguyen HV, Berleau LT, Duarte CM, Park J, Chen H, Ferrara N. Keyt BA, et al. J Biol Chem. 1996 Mar 8;271(10):5638-46. doi: 10.1074/jbc.271.10.5638. J Biol Chem. 1996. PMID: 8621427 Free article.

4

Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression.

Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, Isner JM. Brogi E, et al. J Clin Invest. 1996 Jan 15;97(2):469-76. doi: 10.1172/JCI118437. J Clin Invest. 1996. PMID: 8567969 Free PMC article.

5

The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation.

Walter DH, Hink U, Asahara T, Van Belle E, Horowitz J, Tsurumi Y, Vandlen R, Heinsohn H, Keyt B, Ferrara N, Symes JF, Isner JM. Walter DH, et al. Lab Invest. 1996 Feb;74(2):546-56. Lab Invest. 1996. PMID: 8780172

6

Solution structure of the heparin-binding domain of vascular endothelial growth factor.

Fairbrother WJ, Champe MA, Christinger HW, Keyt BA, Starovasnik MA. Fairbrother WJ, et al. Among authors: keyt ba. Structure. 1998 May 15;6(5):637-48. doi: 10.1016/s0969-2126(98)00065-3. Structure. 1998. PMID: 9634701 Free article.

7

The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: multiple copy flexibility and receptor binding.

Muller YA, Christinger HW, Keyt BA, de Vos AM. Muller YA, et al. Among authors: keyt ba. Structure. 1997 Oct 15;5(10):1325-38. doi: 10.1016/s0969-2126(97)00284-0. Structure. 1997. PMID: 9351807 Free article.

8

Crystallization of the receptor binding domain of vascular endothelial growth factor.

Christinger HW, Muller YA, Berleau LT, Keyt BA, Cunningham BC, Ferrara N, de Vos AM. Christinger HW, et al. Among authors: keyt ba. Proteins. 1996 Nov;26(3):353-7. doi: 10.1002/(SICI)1097-0134(199611)26:3<353::AID-PROT9>3.0.CO;2-E. Proteins. 1996. PMID: 8953654

9

Effects of vascular endothelial growth factor on hemodynamics and cardiac performance.

Yang R, Thomas GR, Bunting S, Ko A, Ferrara N, Keyt B, Ross J, Jin H. Yang R, et al. J Cardiovasc Pharmacol. 1996 Jun;27(6):838-44. doi: 10.1097/00005344-199606000-00011. J Cardiovasc Pharmacol. 1996. PMID: 8761851

10

VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts.

Hariawala MD, Horowitz JR, Esakof D, Sheriff DD, Walter DH, Keyt B, Isner JM, Symes JF. Hariawala MD, et al. J Surg Res. 1996 Jun;63(1):77-82. doi: 10.1006/jsre.1996.0226. J Surg Res. 1996. PMID: 8661176

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters